Open house Drug rebate contracts Pegfilgrastim, ATC L03AA13
AOK Bayern - Die Gesundheitskasse, MünchenTED 673779-2025
value not stated1 lot
Sun 3 Oct12:00 in Berlin
339days
Public tenders in Germany
7,249 open tenders
CountryTenderValueClosesDays left
Open house for pharmaceutical discount agreements for allergen extracts from grass pollen for sublingual use, trade name Oralair(R), ATC V01AA02
AOK Bayern - Die Gesundheitskasse, MünchenTED 674661-2025
value not stated1 lot
Sun 3 Oct12:00 in Berlin
339days
Open house for pharmaceutical discount agreements for Risankizumab, ATC L04AC18
AOK Bayern - Die Gesundheitskasse, MünchenTED 675355-2025
value not stated1 lot
Sun 3 Oct12:00 in Berlin
339days
Open house on pharmaceutical discount agreements for Natalizumab in the form of concentrate for infusion solution, ATC L04AG03
AOK Bayern - Die Gesundheitskasse, MünchenTED 673381-2025
value not stated1 lot
Sun 3 Oct12:00 in Berlin
339days
Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance Aflibercept (excluding 114, 3 mg/ml), ATC S01LA05 for the period 01.12.2025 - 30.11.2027
DAK-Gesundheit, HamburgTED 685877-2025
€11 lot, 2 years
Tue 5 Oct12:00 in Berlin
341days
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the Fifth Book of the German Social Code (SGB V) for the active substance Tocilizumab (infusion concentrate solution only), ATC L04AC07, for the period 01.12.2025 - 30.11.2027
DAK-Gesundheit, HamburgTED 683790-2025
€11 lot, 2 years
Tue 5 Oct12:00 in Berlin
341days
Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance Natalizumab (excl. in the form of IFK), for the period 01.12.25 - 30.11.26 (including extension option 1x12 months)
DAK-Gesundheit, HamburgTED 684299-2025
€11 lot, 1 year
Tue 5 Oct12:00 in Berlin
341days
Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance Haloperidol (exclusively injection solution), ATC N05AD01 for the period 01.12.2025 - 30.11.2027
DAK-Gesundheit, HamburgTED 683809-2025
€11 lot, 2 years
Tue 5 Oct12:00 in Berlin
341days
Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance Doravirin, ATC J05AG06 for the period 01.12.2025 - 30.11.2027
DAK-Gesundheit, HamburgTED 685244-2025
€11 lot, 2 years
Tue 5 Oct12:00 in Berlin
341days
Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance Tocilizumab (exclusively pre-filled syringe and pre-filled pen), ATC L04AC07 for the period 01.12.2025 - 30.11.2027
DAK-Gesundheit, HamburgTED 683943-2025
€11 lot, 2 years
Tue 5 Oct12:00 in Berlin
341days
Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance Sumatriptan (excluding film-coated tablets and tablets), ATC N02CC01 for the period 01.12.2025 - 30.11.2027
DAK-Gesundheit, HamburgTED 684236-2025
€11 lot, 2 years
Tue 5 Oct12:00 in Berlin
341days
Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance Doravirin + Lamivudin + Tenofovirdisoproxilfumarat, ATC J05AR24 for the period 01.12.2025 - 30.11.2027
DAK-Gesundheit, HamburgTED 685134-2025
€11 lot, 2 years
Tue 5 Oct12:00 in Berlin
341days
Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance Leuprorelin, ATC L02AE02 for the period 01.12.2025 - 30.11.2027
DAK-Gesundheit, HamburgTED 685328-2025
€11 lot, 2 years
Tue 5 Oct12:00 in Berlin
341days
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for the active substance Abiraterone (exclusively 500 mg 90 units), ATC L02BX03, for the period 01.12.2025 – 30.11.2027
DAK-Gesundheit, HamburgTED 685930-2025
€11 lot, 2 years
Tue 5 Oct12:00 in Berlin
341days
Open framework agreement on pharmaceutical discounts pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) with possibility of accession at any time, so-called approval model 2025-10
Deutsche Rentenversicherung Knappschaft-Bahn-See, BochumTED 549047-2026
value not stated6 lots
Tue 5 Oct23:59 in Berlin
341days
Conclusion of non-exclusive discount agreements pursuant to § 130a para. 8 SGB V for medicinal products (open-house procedure)
AOK Baden-Württemberg, StuttgartTED 680694-2025
value not stated1 lot
Wed 20 Oct23:59 in Berlin
356days
Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for medicines with the active substance Triptorelin (ATC-Code: L02AE04 and H01CA07)
AOK Niedersachsen. Die Gesundheitskasse., HannoverTED 743721-2025
value not stated1 lot
Wed 27 Oct12:00 in Berlin
363days
Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for medicines with the active substance Aflibercept, excluding 114, 3 mg/ml (ATC-Code: S01LA05)
AOK Niedersachsen. Die Gesundheitskasse., HannoverTED 775350-2025
value not stated1 lot
Wed 27 Oct12:00 in Berlin
363days
Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for medicines with the active substance Ranibizumab (ATC-Code: S01LA04)
AOK Niedersachsen. Die Gesundheitskasse., HannoverTED 746904-2025
value not stated1 lot
Wed 27 Oct12:00 in Berlin
363days
Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for medicines with the active substance Pazopanib (ATC-Code: L01EX03)
AOK Niedersachsen. Die Gesundheitskasse., HannoverTED 744652-2025
value not stated1 lot
Wed 27 Oct12:00 in Berlin
363days
SIMAP: This is not an official publication. The data published on www.simap.ch are authoritative. SIMAP data use is subject to its terms.